# MEDISAFE: FEASIBILITY ANALYSIS
## A Drug Interaction Analyzer for Self-Medication Safety

---

## EXECUTIVE SUMMARY

MediSafe is a web-based application that analyzes drug interactions from prescriptions or self-reported medication lists. Our solution combines OCR technology, FDA-sourced drug databases, and AI-powered analysis to provide accessible drug safety information. This document outlines the technical, market, and operational feasibility of our solution.

---

## 1. PROBLEM STATEMENT

Drug interactions pose a significant public health risk, particularly for individuals who self-medicate or manage multiple prescriptions. According to recent studies:

- **1 in 3** American adults take 3 or more prescription drugs daily
- **70%** of adults take at least one supplement that may interact with medications
- **Over 100,000** hospitalizations annually are attributed to adverse drug events

Current solutions are either too clinical, require medical expertise, or fail to address the self-medicating population. There is a clear gap in the market for an accessible, user-friendly tool that empowers individuals to understand their medication risks.

---

## 2. TECHNICAL FEASIBILITY

### 2.1 Technology Architecture

Our solution employs a modern, lightweight architecture that prioritizes speed, accessibility, and privacy:

| Component | Technology | Purpose |
|----------|------------|---------|
| Frontend | React + Vite | Fast, responsive user interface |
| Styling | Tailwind CSS | Modern, accessible design |
| OCR Engine | Tesseract.js | Prescription text extraction |
| Drug Database | RxLabelGuard API | FDA-sourced interaction data |
| AI Analysis | WebLLM (Llama) | Local, privacy-preserving AI |
| Hosting | Vercel | Free, global CDN deployment |

### 2.2 Key Technical Achievements

**Client-Side Processing:** Our application performs all analysis in the user's browser. No sensitive medical data is transmitted or stored on external servers, ensuring complete privacy compliance.

**Offline Capability:** The WebLLM integration allows AI analysis to run locally without internet connectivity after initial model loading, making it resilient and fast.

**Multi-Format Support:** Users can upload prescriptions as PDF or image files, with our OCR engine extracting drug names automatically.

### 2.3 Technical Risk Assessment

| Risk | Level | Mitigation Strategy |
|------|-------|-------------------|
| OCR accuracy on handwritten prescriptions | Medium | Manual correction interface included |
| WebLLM loading time on first use | Low | Progressive loading with status indicators |
| API rate limits (free tier) | Medium | Local mock data fallback for demo |
| Browser compatibility | Low | Tested on modern browsers (Chrome, Firefox, Safari) |

---

## 3. MARKET FEASIBILITY

### 3.1 Target Audience

Our primary target market consists of:

1. **Self-medicating individuals** (18-55 years): Adults who occasionally self-prescribe over-the-counter medications without consulting healthcare providers.

2. **Caregivers** (35-65 years): Family members managing medications for elderly parents or children, needing quick interaction checks.

3. **Health-conscious individuals** (25-50 years): Users who research medications online and want a reliable tool to cross-check their combinations.

### 3.2 Market Validation

- Growing health awareness has increased demand for self-service medical tools
- 77% of adults search online for health information before consulting doctors
- Mobile health app market expected to reach $332 billion by 2025
- No major free, consumer-friendly drug interaction tools exist in the market

### 3.3 Competitive Landscape

| Competitor | Strength | Weakness |
|------------|----------|----------|
| Drugs.com | Comprehensive data | Clinical interface, overwhelming for consumers |
| WebMD | Trusted brand | Complex, cluttered interface |
| Pharmacy apps | Integration with records | Limited to their medications |

Our differentiation: **Simplicity, accessibility, and beautiful design that anyone can use.**

---

## 4. FINANCIAL FEASIBILITY

### 4.1 Development Costs (Hackathon Phase)

| Item | Cost | Notes |
|------|------|-------|
| Development time | 24 hours | Team effort |
| Domain registration | $12/year | Optional for MVP |
| API usage | $0 | Using free tiers |
| Hosting | $0 | Vercel free tier |

**Total MVP Cost: $0-12**

### 4.2 Operational Costs (Post-Hackathon)

For a minimum viable product serving 1,000 monthly users:

| Service | Monthly Cost |
|---------|--------------|
| RxLabelGuard API | $0-20 |
| Hosting (Vercel Pro) | $20 |
| Domain | $1 |
| **Total** | **$21-41/month** |

### 4.3 Revenue Model

1. **Freemium Model:** Free tier with 10 monthly checks, premium subscription at $4.99/month for unlimited checks.

2. **Healthcare Partnerships:** B2B licensing to pharmacies and clinics at $99/month per location.

3. **Affiliate Revenue:** Partnership with telehealth providers and online pharmacies.

**Break-even projection:** 200 premium subscribers or 10 healthcare partners.

---

## 5. LEGAL AND COMPLIANCE FEASIBILITY

### 5.1 Privacy Compliance

Our architecture inherently addresses privacy concerns:

- **No data storage:** User information is never stored on servers
- **Client-side processing:** All analysis happens locally in the browser
- **No accounts required:** Users can immediately start using the tool

### 5.2 Medical Disclaimer Framework

To ensure legal compliance, our application includes:

1. Prominent disclaimer: "This tool is for informational purposes only and does not replace professional medical advice."

2. Doctor referral prompts: Users are encouraged to consult healthcare providers at multiple stages.

3. Evidence citations: All interaction data is sourced from FDA-approved labels.

### 5.3 Regulatory Considerations

- Not classified as a medical device under current FDA guidelines
- Standard consumer application disclaimers are sufficient
- No HIPAA requirements due to no data storage model

---

## 6. OPERATIONAL FEASIBILITY

### 6.1 Development Timeline

| Phase | Duration | Deliverable |
|-------|----------|-------------|
| UI/UX Development | 8 hours | All screen designs implemented |
| API Integration | 4 hours | Drug interaction checking functional |
| OCR Implementation | 4 hours | Prescription upload and extraction |
| AI Analysis | 4 hours | WebLLM integration for insights |
| Testing & Polish | 4 hours | Bug fixes, responsive design |
| **Total** | **24 hours** | **Production-ready MVP** |

### 6.2 Scalability Considerations

The current architecture supports:

- Horizontal scaling via CDN (Vercel edge network)
- Database-free design eliminates scaling bottlenecks
- API rate limits can be addressed with paid tiers as usage grows

### 6.3 Maintenance Requirements

- API key updates (when changing plans)
- Periodic dependency updates (monthly)
- WebLLM model updates (quarterly)
- Content refresh for common questions (as needed)

---

## 7. IMPACT ASSESSMENT

### 7.1 Social Benefit

- **Empowers patients:** Gives individuals tools to understand their medications
- **Prevents harm:** Early detection of dangerous drug combinations
- **Reduces healthcare burden:** Prevents unnecessary hospitalizations
- **Improves health literacy:** Educates users about drug safety

### 7.2 Accessibility Impact

Our design prioritizes accessibility for all age groups:

- Large, readable fonts (minimum 16px)
- High contrast colors meeting WCAG AA standards
- Simple, intuitive navigation
- Clear iconography with text labels
- Screen reader compatibility

---

## 8. CONCLUSION

### Feasibility Verdict: ✅ HIGHLY FEASIBLE

| Dimension | Assessment |
|-----------|------------|
| Technical | ✅ Achievable with current technology |
| Market | ✅ Clear need with growing demand |
| Financial | ✅ Near-zero cost for MVP |
| Legal | ✅ Compliant with proper disclaimers |
| Operational | ✅ 24-hour hackathon timeline is realistic |

### Key Success Factors

1. **Simplicity wins:** Our clean, intuitive interface differentiates us from clinical alternatives.

2. **Privacy by design:** No data storage model eliminates compliance and trust concerns.

3. **Free to build:** Leveraging free tiers and client-side processing keeps costs minimal.

4. **Real problem:** Drug interactions are a genuine public health concern with no simple consumer solution.

### Recommendations for Next Steps

1. Secure API key for full RxLabelGuard integration
2. Conduct user testing with target demographic
3. Add more common drug combinations to mock database
4. Develop mobile-responsive polish
5. Explore telehealth partnerships for revenue generation

---

**Prepared for:** Randomize Hackathon Presentation
**Date:** March 2026
**Version:** 1.0

---
